• Non ci sono risultati.

Belza - Lock antimicrobico non antibiotico

N/A
N/A
Protected

Academic year: 2021

Condividi "Belza - Lock antimicrobico non antibiotico"

Copied!
28
0
0

Testo completo

(1)

New frontiers of infection

prevention: the non-antibiotic

antimicrobial lock

Christina Belza

PhD(c), MN, RN

Group for Improvement of Intestinal Function and Treatment (GIFT),

The Hospital for Sick Children,

(2)

Disclosure

(3)
(4)

Why Is It Important?

Morbidity

Mortality

(5)
(6)

Prevention of CLABSI

(7)

Locking Solutions in Home PN Population at Sickkids

– Heparin

(8)
(9)

Challenges

Line Complications

Availability

(10)

Thrombus

Bacterial

Colonization

Biofilm

Formation

What are We Trying to Treat?

(11)
(12)
(13)

Taurolidine

(14)

Thrombus

Bacterial

Colonization

Biofilm

Formation

(15)

Tetrasodium EDTA

Anticoagulant

Antimicrobial

Prevent biofilm

Eliminate biofilm

Not an antibiotic

Proescher 1951. Proceedings of the Society for Experimental Biology and Medicine. 76(4):

Kanaa et al, 2015. Am J Kidney Dis, 66(6):1015-1023.

(16)

Canadian Clinical Isolates

EDTA Time to kill:

(17)

0

10

20

30

40

50

60

70

80

EDTA dose in mg/kg

Chelation dose (max)

Chelation dose (min)

KiteLock dose

2 lumens 1 lumen

Safety Profile of Kitelock 4% Sterile Catheter Lock Solution

mg/

kg

(18)

Our Experience

• Outpatient

• History of line infections or recurrent blockages

• Procedure for home:

– Instill 1 ml at end of cycle time (port volume = 3ml)

(19)

Methods for Evaluation

Kitelock

Initiation

(20)

Methods for Evaluation

• Infection Rate

• Alteplase Use

• Line exchange

ü

Wilcoxon

matched-pairs

signed-rank test

ü

Medians (IQR) &

frequencies

(proportions)

ü

Alpha value

(21)
(22)

Results

0 0,2 0,4 0,6 0,8 1 1,2 1,4

Pre-Kitelock

Post-Kitelock

Infections

1,4

0

1,4

0

CLABSI Rate in Patients Previously on

Ethanol (n=10)

0 0,5 1 1,5 2 2,5 3

Pre-Kitelock

Post-Kitelock

Infections

2,7

0

2,7

0

Ra te p e r 1 0 0 0 c a th e te r d a y s

CLABSI Rate in Total Cohort

(23)

Results

0 1 2 3 4 5 6

Pre-Kitelock

Post-Kitelock

Occlusions

5,5

2,7

5,5

2,7

Occlusion Rate per 1000 catheter days in Children with history of

alteplase use

(24)

Safety Concerns

Calcium

Anemia

(25)
(26)

Conclusion

• Majority of CLABSIs are preventable

• CLABSIs have significant impact on patient and health

care system

• Tetrasodium EDTA has shown early promise in

intestinal failure population for prevention of CLABSI

and line occlusions

(27)
(28)

References

• McKnight, Sherry; “Nurses Guide to Understanding and Treating Thrombotic Occlusion of Central Venous Access Devices” MedSurg Nursing, December 2004, Volume 13/No.6 • Hadaway, Lynn “Heparin Locking for Central Venous Catheters; JAVA, Volume 11 No 4 2006

• http://www.citra-lock.com/index.php/en/science-behind/citrate-of-choice.html

• Shanks, Robert M.Q. “Heparin Stimulates Staphylococcus aureus Biofilm Formation” Infection and Immunity, Aug 2005, p 4596-4606 • Ryder, Marcia “Catheter-Related Infections: It’s All About Biofilm” Advanced Practise Nursing Journal 2005: 5 (3)

Fowler VG Jr, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30:1072-1078.

• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-532.

• Mermel, LA; Alang N2; “Adverse effects associated with ethanol catheter lock solutions: a systemic review” Epub 2014 June 2

• Guembe, M et al, 2016. Sonicating multi-lumen sliced catheter tips after roll-plate technique improved the detection of catheter colonization in adults. Journal of Microbiological Methods, 122:20-22.

• Schiffer et al, 2013. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology, 31(10):1357-1370.

• Rock et al, 2015. A multicenter longitudinal study of hospital-onset bacteremia: Time for a new quality outcome measure? Infect Control Hosp Epidemiol, 23:1-6.

• Kaur et al, 2015. Incidence, risk factors, microbiology of venous catheter-associated bloodstream infection - A prospective study from tertiary care hospital. Indian J Med Microbiol, 33:248-254.

• Strasheim et al, 2015. Surveillance of catheter-related infections: the supplementary role of the microbiology laboratory. BMC Infectious Diseases, doi:10.1186/s12879-014-0743-5. • Gossens, GA, 2015. Flushing and locking of venous catheters: Available evidence and evidence deficit. Nursing Research and Practice, p1-12.

Riferimenti

Documenti correlati

In particolare, i 20 microrganismi isolati (tutti gli isolamenti erano monomicrobici) parallelamente da CVC ed emo- coltura sono stati 10 Gram-positivi (4 S. famata) (figura II)..

•  The baseline risk of developing prostate cancer of any stage is likely higher than that of the general population (estimated at about 51 per 1000 men diagnosed), and

In an intermediate PTP population where the prevalence is lower, other potentially acceptable strat- egies include proximal lower extremity ultrasound alone with no additional

These clinical practice guidelines include a strong recommendation that patients who are at high risk for extubation failure and who have passed an SBT be extubated to preventive

The outcomes con- sidered were those reported in the following list as published in (11): disease remission, disease relapse, duration of glucocorticoid therapy, discontinuation

RA, Rheumatoid Arthritis; MTX, Methotrexate; LFN, Leflunomide; SSZ, sulfasalazine; csDMARD, conventional synthetic disease- modifying antirheumatic drug; bDMARD,

This Clinical Practice Guideline (CPG) evaluates the scientific and research literature for the initial assessment and evaluation of patients who present to the emergency setting

This authorization includes a full authorization to prescribe methadone for analgesia and a limited authorization to prescribe methadone for opioid dependence, which does not